156 related articles for article (PubMed ID: 8910598)
1. Role of arginine 132 and lysine 133 in heparin binding to and activation of antithrombin.
Meagher JL; Huntington JA; Fan B; Gettins PG
J Biol Chem; 1996 Nov; 271(46):29353-8. PubMed ID: 8910598
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of heparin activation of antithrombin. Evidence for reactive center loop preinsertion with expulsion upon heparin binding.
Huntington JA; Olson ST; Fan B; Gettins PG
Biochemistry; 1996 Jul; 35(26):8495-503. PubMed ID: 8679610
[TBL] [Abstract][Full Text] [Related]
3. Lysine-heparin interactions in antithrombin. Properties of K125M and K290M,K294M,K297M variants.
Fan B; Turko IV; Gettins PG
Biochemistry; 1994 Nov; 33(47):14156-61. PubMed ID: 7947827
[TBL] [Abstract][Full Text] [Related]
4. Elimination of P1 arginine 393 interaction with underlying glutamic acid 255 partially activates antithrombin III for thrombin inhibition but not factor Xa inhibition.
Jairajpuri MA; Lu A; Bock SC
J Biol Chem; 2002 Jul; 277(27):24460-5. PubMed ID: 11971909
[TBL] [Abstract][Full Text] [Related]
5. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement.
Olson ST; Björk I; Sheffer R; Craig PA; Shore JD; Choay J
J Biol Chem; 1992 Jun; 267(18):12528-38. PubMed ID: 1618758
[TBL] [Abstract][Full Text] [Related]
6. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
[TBL] [Abstract][Full Text] [Related]
7. The allosteric mechanism of activation of antithrombin as an inhibitor of factor IXa and factor Xa: heparin-independent full activation through mutations adjacent to helix D.
Dementiev A; Swanson R; Roth R; Isetti G; Izaguirre G; Olson ST; Gettins PGW
J Biol Chem; 2013 Nov; 288(47):33611-33619. PubMed ID: 24068708
[TBL] [Abstract][Full Text] [Related]
8. Specificity of the basic side chains of Lys114, Lys125, and Arg129 of antithrombin in heparin binding.
Schedin-Weiss S; Arocas V; Bock SC; Olson ST; Björk I
Biochemistry; 2002 Oct; 41(41):12369-76. PubMed ID: 12369826
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of heparin activation of antithrombin: evidence for an induced-fit model of allosteric activation involving two interaction subsites.
Desai UR; Petitou M; Björk I; Olson ST
Biochemistry; 1998 Sep; 37(37):13033-41. PubMed ID: 9737884
[TBL] [Abstract][Full Text] [Related]
10. The role of Arg46 and Arg47 of antithrombin in heparin binding.
Arocas V; Bock SC; Olson ST; Björk I
Biochemistry; 1999 Aug; 38(31):10196-204. PubMed ID: 10433728
[TBL] [Abstract][Full Text] [Related]
11. Lysine residue 114 in human antithrombin III is required for heparin pentasaccharide-mediated activation.
Kridel SJ; Knauer DJ
J Biol Chem; 1997 Mar; 272(12):7656-60. PubMed ID: 9065421
[TBL] [Abstract][Full Text] [Related]
12. Heparin binding site, conformational change, and activation of antithrombin.
Evans DL; Marshall CJ; Christey PB; Carrell RW
Biochemistry; 1992 Dec; 31(50):12629-42. PubMed ID: 1366018
[TBL] [Abstract][Full Text] [Related]
13. Importance of lysine 125 for heparin binding and activation of antithrombin.
Schedin-Weiss S; Desai UR; Bock SC; Gettins PG; Olson ST; Björk I
Biochemistry; 2002 Apr; 41(15):4779-88. PubMed ID: 11939772
[TBL] [Abstract][Full Text] [Related]
14. Conformational conversion of antithrombin to a fully activated substrate of factor Xa without need for heparin.
Huntington JA; Gettins PG
Biochemistry; 1998 Mar; 37(10):3272-7. PubMed ID: 9521646
[TBL] [Abstract][Full Text] [Related]
15. Energetics of hydrogen bond switch, residue burial and cavity analysis reveals molecular basis of improved heparin binding to antithrombin.
Singh P; Singh K; Jairajpuri MA
J Biomol Struct Dyn; 2011 Oct; 29(2):339-50. PubMed ID: 21875153
[TBL] [Abstract][Full Text] [Related]
16. The oligosaccharide side chain on Asn-135 of alpha-antithrombin, absent in beta-antithrombin, decreases the heparin affinity of the inhibitor by affecting the heparin-induced conformational change.
Turk B; Brieditis I; Bock SC; Olson ST; Björk I
Biochemistry; 1997 Jun; 36(22):6682-91. PubMed ID: 9184148
[TBL] [Abstract][Full Text] [Related]
17. Antithrombin III phenylalanines 122 and 121 contribute to its high affinity for heparin and its conformational activation.
Jairajpuri MA; Lu A; Desai U; Olson ST; Bjork I; Bock SC
J Biol Chem; 2003 May; 278(18):15941-50. PubMed ID: 12556442
[TBL] [Abstract][Full Text] [Related]
18. The region of antithrombin interacting with full-length heparin chains outside the high-affinity pentasaccharide sequence extends to Lys136 but not to Lys139.
Arocas V; Turk B; Bock SC; Olson ST; Björk I
Biochemistry; 2000 Jul; 39(29):8512-8. PubMed ID: 10913257
[TBL] [Abstract][Full Text] [Related]
19. Conformational equilibrium of the reactive center loop of antithrombin examined by steady state and time-resolved fluorescence measurements: consequences for the mechanism of factor Xa inhibition by antithrombin-heparin complexes.
Futamura A; Beechem JM; Gettins PG
Biochemistry; 2001 Jun; 40(22):6680-7. PubMed ID: 11380263
[TBL] [Abstract][Full Text] [Related]
20. Antithrombin 'DREUX' (Lys 114Glu): a variant with complete loss of heparin affinity.
Mushunje A; Zhou A; Huntington JA; Conard J; Carrell RW
Thromb Haemost; 2002 Sep; 88(3):436-43. PubMed ID: 12353073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
